Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	30.31M +28.1%
Revenue (ttm)	17.11M +6.4%
Net Income	2.39M +32.7%
EPS	0.25 +32.5%
Shares Out	9.50M
PE Ratio	12.67
Forward PE	n/a
Dividend	0.22 (6.90%)
Ex-Dividend Date	Apr 10, 2025

Volume	200
Average Volume	1,073
Open	3.190
Previous Close	3.100
Day's Range	3.190 - 3.190
52-Week Range	2.630 - 3.350
Beta	0.04
RSI	47.42
Earnings Date	Feb 12, 2026

About ASE:HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 234
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2024, ASE:HPIC's revenue was 16.71 million, an increase of 5.72% compared to the previous year's 15.81 million. Earnings were 3.09 million, an increase of 32.73%.